Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis

BACKGROUND: Platinum-based chemotherapy improves survival among patients with non-small cell lung cancer (NSCLC), but the efficiency is limited due to resistance. In this study, we aimed to identify the expression of Aurora-A and its correlation with cisplatin resistance and prognosis in NSCLC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Yue, Cai-feng, Zhou, Wei-hua, Qian, Yuan-min, Zhang, Yan, Wang, Shao-wu, Liu, An-wen, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237886/
https://www.ncbi.nlm.nih.gov/pubmed/25082261
http://dx.doi.org/10.1186/1479-5876-12-200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237886/
https://www.ncbi.nlm.nih.gov/pubmed/25082261
http://dx.doi.org/10.1186/1479-5876-12-200

Ejemplares similares